Healthcare and consumer products giant Johnson & Johnson on Tuesday reported a 29 percent decline in profit for the third quarter from last year, reflecting one-time charges and lower sales that were hurt by a strong dollar. However, adjusted earnings per share beat analysts’ expectations, while revenues missed their estimates.